Market Cap

Vicore Pharma Holding AB Market Capitalization:

kr2.13 Billion

SEK as of July 1, 2024

US$201.1 Million

business Vicore Pharma Holding AB Company Profile

Vicore Pharma Holding AB Main Stock Listing

OMX: VICO

Market Capitalization History of Vicore Pharma Holding AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Vicore Pharma Holding AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr1.60 B -6.70%
Jan. 1, 2023 kr1.71 B 38.86%
Jan. 1, 2022 kr1.23 B -50.35%
Jan. 1, 2021 kr2.49 B 97.89%
Jan. 1, 2020 kr1.26 B -15.68%
Jan. 1, 2019 kr1.49 B 25.71%
Jan. 1, 2018 kr1.19 B 1.94%
Jan. 1, 2017 kr1.16 B 168.66%
Jan. 1, 2016 kr433.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Vicore Pharma Holding AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Vicore Pharma Holding AB has the following listings and related stock indices.


Stock: OMX: VICO

Stock: FSX: 6Y4

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.